The second quarter earnings season is about to kick off! Are you expecting any surprises? Who's going to beat expectations? Who's going to disappoint? Here's what I'll be watching for!
I just had a call with management. Yeah I think the thesis remains pretty much the same. They bounced back from a weaker Q1 and showed positive EBITDA again in Q2. The goal remains to sell two non-core assets (DaMar and South Dakota Partners) to clean up the debt. They have several growth opportunities with their remaining core asset, Biodex. It might take another six months or so to finish cleaning everything up. Until then, the situation might remain somewhat unclear and perceived as risky by the market.
What are your views based on the latest Evome earnings? Is the thesis still intact?
I just had a call with management. Yeah I think the thesis remains pretty much the same. They bounced back from a weaker Q1 and showed positive EBITDA again in Q2. The goal remains to sell two non-core assets (DaMar and South Dakota Partners) to clean up the debt. They have several growth opportunities with their remaining core asset, Biodex. It might take another six months or so to finish cleaning everything up. Until then, the situation might remain somewhat unclear and perceived as risky by the market.
Thanks, would you happen to have the recording you can share from your call with management?
I don't, but they're doing an investor webinar next Monday. If you want to get an update and ask questions it will be a great opportunity!